Anika Therapeutics, Inc. (ANIK)
21.31
-0.47
(-2.16%)
USD |
NASDAQ |
Aug 24, 16:00
21.31
0.00 (0.00%)
After-Hours: 20:00
Anika Therapeutics EPS Diluted (Quarterly) : 0.2412 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.2412 |
| March 31, 2026 | -0.3737 |
| December 31, 2025 | 0.0199 |
| September 30, 2025 | -0.1615 |
| June 30, 2025 | -0.2764 |
| March 31, 2025 | -0.3408 |
| December 31, 2024 | -1.50 |
| September 30, 2024 | -2.026 |
| June 30, 2024 | -0.0059 |
| March 31, 2024 | -0.3071 |
| December 31, 2023 | -4.30 |
| September 30, 2023 | -0.4493 |
| June 30, 2023 | -0.1866 |
| March 31, 2023 | -0.7063 |
| December 31, 2022 | -0.3352 |
| September 30, 2022 | -0.2859 |
| June 30, 2022 | -0.1953 |
| March 31, 2022 | -0.2028 |
| December 31, 2021 | -0.4012 |
| September 30, 2021 | 0.0381 |
| June 30, 2021 | 0.4465 |
| March 31, 2021 | 0.1966 |
| December 31, 2020 | -1.097 |
| September 30, 2020 | -0.4513 |
| June 30, 2020 | -0.5429 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.4036 |
| December 31, 2019 | 0.2771 |
| September 30, 2019 | 0.6395 |
| June 30, 2019 | 0.6697 |
| March 31, 2019 | 0.3149 |
| December 31, 2018 | 0.5397 |
| September 30, 2018 | 0.53 |
| June 30, 2018 | 0.68 |
| March 31, 2018 | -0.46 |
| December 31, 2017 | 0.53 |
| September 30, 2017 | 0.46 |
| June 30, 2017 | 0.76 |
| March 31, 2017 | 0.37 |
| December 31, 2016 | 0.54 |
| September 30, 2016 | 0.59 |
| June 30, 2016 | 0.57 |
| March 31, 2016 | 0.45 |
| December 31, 2015 | 0.72 |
| September 30, 2015 | 0.55 |
| June 30, 2015 | 0.51 |
| March 31, 2015 | 0.23 |
| December 31, 2014 | 0.51 |
| September 30, 2014 | 0.40 |
| June 30, 2014 | 0.60 |
| March 31, 2014 | 0.97 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Perspective Therapeutics, Inc. | -0.222 |
| MiMedx Group, Inc. | -0.1004 |
| ABVC BioPharma, Inc. | -0.0283 |
| Enovis Corp. | -0.0207 |
| Edwards Lifesciences Corp. | 0.4188 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 3.309M |
| Revenue (Quarterly) | 32.61M |
| Total Expenses (Quarterly) | 29.30M |
| Enterprise Value | 278.32M |
| Gross Profit Margin (Quarterly) | 65.15% |
| Profit Margin (Quarterly) | 10.15% |
| Earnings Yield | -1.29% |
| Normalized Earnings Yield | -1.286 |